Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
blueprint medicines
3
×
boston blog main
3
×
boston top stories
life sciences
national blog main
national top stories
roche
san francisco blog main
san francisco top stories
3
×
avapritinib
biotech
boston
cancer
clinical trials
eli lilly
fda
genentech
indiana blog main
indiana top stories
medullary thyroid cancer
non-small cell lung cancer
pralsetinib
selpercatinib
thyroid cancer
boulder/denver blog main
boulder/denver top stories
cancer drugs
capmatinib
companion diagnostic
cstone pharmaceuticals
deals
detroit blog main
detroit top stories
dna sequencing
drugs
entrectinib
europe blog main
europe top stories
european medicines agency
express scripts
What
cancer
drug
fda
3
×
approval
blueprint
genetic
medicines
ret
address
approved
approves
candidate
carries
certain
currently
deeper
designed
dna
fingerprint
going
latest
marketing
matter
medicine
muscle
nd
new
oks
pact
pass
regulatory
review
roche
second
signature
signatures
targeted
targeting
targets
team
Language
unset
Current search:
photo
×
fda
×
" san francisco top stories "
×
" boston blog main "
×
" blueprint medicines "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues